IV 
117TH CONGRESS 
2D SESSION 
H. RES. 1072 
Expressing support for the designation of April 30, 2022, as ‘‘National 
Adult Hepatitis B Vaccination Awareness Day’’. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 28, 2022 
Mr. JOHNSON of Georgia (for himself, Ms. MENG, Mr. FITZPATRICK, Ms. 
DEAN, Mr. CLEAVER, Mr. COHEN, Mr. CASE, Ms. SEWELL, Mrs. 
CHERFILUS-MCCORMICK, Ms. CHU, Mrs. WATSON COLEMAN, Ms. WIL-
LIAMS of Georgia, Ms. LEE of California, Mr. SMITH of Washington, and 
Mr. BACON) submitted the following resolution; which was referred to the 
Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of April 30, 2022, 
as ‘‘National Adult Hepatitis B Vaccination Awareness Day’’. 
Whereas up to 2.4 million individuals in the United States 
are chronically infected with hepatitis B, and up to two- 
thirds of individuals with chronic hepatitis B are unaware 
of their infection status; 
Whereas hepatitis B is a viral infection of the liver trans-
mitted via infected blood and other body fluids, including 
through mother-to-child transmission and injection drug 
use; 
Whereas hepatitis B is associated with significant disparities 
among communities of color (including Asian Americans, 
VerDate Sep 11 2014 
00:04 Apr 29, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1072.IH
HR1072
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1072 IH 
Pacific Islanders, and African immigrants), sexual and 
gender minority communities, and those affected by the 
opioid crisis; 
Whereas individuals with chronic diseases such as diabetes, 
HIV, hepatitis C, and chronic liver disease, and individ-
uals on hemodialysis are at an increased risk for hepatitis 
B co-infection; 
Whereas there is no cure for hepatitis B and individuals with 
chronic hepatitis B require lifelong medical care; 
Whereas chronic hepatitis B represents one of the most com-
mon causes of liver cancer; 
Whereas 1 in every 4 individuals with unmanaged chronic 
hepatitis B will develop liver cancer, cirrhosis, or liver 
failure, with liver cancer having a 5-year-survival rate of 
only 18 percent in the United States; 
Whereas safe and highly effective vaccines to protect against 
hepatitis B are available; 
Whereas in accordance with universal childhood hepatitis B 
vaccination recommendations in the United States, in-
fants and children have been routinely vaccinated against 
hepatitis B since the 1990s; 
Whereas all adults aged 19 to 59, and adults 60 and older 
with hepatitis B risk factors, are recommended to be vac-
cinated against hepatitis B; 
Whereas the hepatitis B vaccine, which is 95 percent effective 
and was the first anticancer vaccine to be developed, is 
projected to have prevented 310 million cases of hepatitis 
B worldwide from 1990 to 2020; 
Whereas only 30 percent of adults in the United States are 
vaccinated against hepatitis B; 
VerDate Sep 11 2014 
00:04 Apr 29, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1072.IH
HR1072
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1072 IH 
Whereas the number of reported acute hepatitis B cases in-
creased by 11 percent nationwide between 2014 and 
2018; 
Whereas as a result of the opioid epidemic, there have been 
significant regional increases in acute hepatitis B cases 
in the United States, including— 
(1) a 489 percent increase in acute hepatitis B in-
fections from 2015 to 2016 in Maine; 
(2) a reported 114 percent increase from 2009 to 
2013 in Kentucky, West Virginia, and Tennessee; 
(3) a reported 78 percent increase in 2017 in south-
eastern Massachusetts; and 
(4) a reported 56 percent increase from 2014 to 
2016 in North Carolina; 
Whereas 36 percent of new hepatitis B cases are among peo-
ple who inject drugs; 
Whereas according to the Centers for Disease Control and 
Prevention, hepatitis B is 50 to 100 times more infec-
tious than HIV and 5 to 10 times more infectious than 
hepatitis C; and 
Whereas there are significant opportunities, particularly with-
in the setting of the opioid epidemic, to prevent new hep-
atitis B infections and thereby reduce the incidence of 
liver cancer and cirrhosis through efforts to— 
(1) increase adult hepatitis B vaccination; and 
(2) maintain childhood hepatitis B vaccination: Now, 
therefore, be it 
Resolved, That the House of Representatives— 
(1) supports the designation of ‘‘National Adult 
Hepatitis B Vaccination Awareness Day’’; 
VerDate Sep 11 2014 
00:04 Apr 29, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR1072.IH
HR1072
kjohnson on DSK79L0C42PROD with BILLS
•HRES 1072 IH 
(2) recognizes the importance of providing sup-
port and encouragement— 
(A) for all individuals to be tested for hep-
atitis B; 
(B) for individuals susceptible to infection 
to be vaccinated against hepatitis B; and 
(C) for individuals diagnosed with hepatitis 
B to be linked to appropriate care; and 
(3) in order to reduce the number of new hepa-
titis B infections and hepatitis B-related deaths, en-
courages a commitment to— 
(A) increasing adult hepatitis B vaccina-
tion rates; 
(B) maintaining childhood hepatitis B vac-
cination rates; and 
(C) promoting provider and community 
awareness of adult hepatitis B vaccination. 
Æ 
VerDate Sep 11 2014 
00:04 Apr 29, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1072.IH
HR1072
kjohnson on DSK79L0C42PROD with BILLS